High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study

Background: Elevated homocysteine concentrations may contributetocognitiveimpairment.Mostelevationsinhomocysteineresult frominadequatefolate,vitaminB-12,orvitaminB-6intake.Itisnot clear whether the observed associations between homocysteine and cognitive measures are causal or whether they are due to homocysteine, to independent actions of the B vitamins, or to both. Objective: We aimed to assess the individual and independent effects of baseline plasma homocysteine, folate, vitamin B-12, and vitamin B-6 and of dietary B vitamin intakes on 3-y changes in cognitive measures in 321 aging men. Design: Participants were from the Veterans Affairs Normative AgingStudy.CognitivefunctionwasassessedwiththeMini-Mental State Examination and on the basis of measures of memory, verbal fluency, and constructional praxis, which were adapted from the revised Wechsler Adult Intelligence Scale and the Consortium to Establish a Registry for Alzheimer’s Disease batteries at 2 time points. At baseline, dietary intakes were assessed with a foodfrequency questionnaire, and blood was drawn for the measurement of B vitamins and homocysteine. Results: Over a mean 3-y follow-up, declines in constructional praxis, measured by spatial copying, were significantly associated with plasma homocysteine, folate, and vitamins B-6 and B-12 and with the dietary intake of each vitamin. Folate (plasma and dietary) remainedindependentlyprotectiveagainstadeclineinspatialcopying score after adjustment for other vitamins and for plasma homocysteine. Dietary folate was also protective against a decline in verbal fluency. A high homocysteine concentration was associated with a decline in recall memory. Conclusions:LowBvitaminandhighhomocysteineconcentrations predict cognitive decline. Spatial copying measures appear to be most sensitive to these effects in a general population of aging men. Am J Clin Nutr 2005;82:627–35.

[1]  M. Fava,et al.  Nutrition and depression: the role of folate. , 2009, Nutrition reviews.

[2]  M. Freedman,et al.  Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  Samuel Patz,et al.  Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  R. Mayeux,et al.  Dietary factors and Alzheimer's disease , 2004, The Lancet Neurology.

[5]  J. Thomas,et al.  A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. , 2004, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[6]  A. Bava,et al.  Vitamin B12 and folate depletion in cognition: a review. , 2004, Neurology India.

[7]  M. Siebler,et al.  Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity , 2004, Journal of the Neurological Sciences.

[8]  S. A. Areosa,et al.  Folic acid with or without vitamin B12 for cognition and dementia. , 2003, The Cochrane database of systematic reviews.

[9]  R. Malouf,et al.  Vitamin B6 for cognition , 2003 .

[10]  R. Malouf,et al.  Vitamin B12 for cognition. , 2003, The Cochrane database of systematic reviews.

[11]  C. Dufouil,et al.  Homocysteine, white matter hyperintensities, and cognition in healthy elderly people , 2003, Annals of neurology.

[12]  T. Shea,et al.  Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage , 2002, Journal of neuroscience research.

[13]  A Hofman,et al.  Homocysteine and cognitive function in the elderly , 2002, Neurology.

[14]  Kevin M Bradley,et al.  Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. , 2002, Age and ageing.

[15]  I. Pogribny,et al.  Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. , 2002, The Journal of nutrition.

[16]  C. Maxwell,et al.  Serum Folate Levels and Subsequent Adverse Cerebrovascular Outcomes in Elderly Persons , 2002, Dementia and Geriatric Cognitive Disorders.

[17]  A. Smith,et al.  Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. , 2002, Archives of neurology.

[18]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[19]  M. Mattson,et al.  Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[20]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[21]  J. Bryan,et al.  B vitamins, cognition, and aging: a review. , 2001, The journals of gerontology. Series B, Psychological sciences and social sciences.

[22]  A. McCaddon,et al.  Homocysteine and Cognitive Decline in Healthy Elderly , 2001, Dementia and Geriatric Cognitive Disorders.

[23]  D. Ashline,et al.  Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stress , 2001 .

[24]  C. Whitlatch,et al.  Are persons with cognitive impairment able to state consistent choices? , 2001, The Gerontologist.

[25]  B. Winblad,et al.  Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.

[26]  H. Arai,et al.  Elevated Plasma Homocysteine Levels and Risk of Silent Brain Infarction in Elderly People , 2001, Stroke.

[27]  P. Elwood,et al.  Homocysteine and ischaemic stroke in men: the Caerphilly study , 2001, Journal of epidemiology and community health.

[28]  Nutrition Board,et al.  Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline , 2000 .

[29]  W. Markesbery,et al.  Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. , 2000, The American journal of clinical nutrition.

[30]  I. Rosenberg,et al.  B vitamins, homocysteine, and neurocognitive function in the elderly. , 2000, The American journal of clinical nutrition.

[31]  R. D'Agostino,et al.  Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study , 1999, Annals of Internal Medicine.

[32]  A. Hofman,et al.  Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. , 1999, American journal of epidemiology.

[33]  J. Manson,et al.  Homocysteine and risk of cardiovascular disease among postmenopausal women. , 1999, JAMA.

[34]  M. Hennerici,et al.  Homocysteine in cerebral macroangiography and microangiopathy , 1999, The Lancet.

[35]  L. Bailey,et al.  Folate metabolism and requirements. , 1999, The Journal of nutrition.

[36]  A. Hoes,et al.  Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. , 1999, Archives of internal medicine.

[37]  C. Chung,et al.  Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. , 1998, Stroke.

[38]  S. Kittner,et al.  Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1998, Stroke.

[39]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[40]  A. Folsom,et al.  Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. , 1998, Circulation.

[41]  D. Hogan,et al.  Folate status, vascular disease and cognition in elderly Canadians. , 1998, Age and ageing.

[42]  J. Cutler,et al.  Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[43]  L. Parnetti,et al.  Role of homocysteine in age-related vascular and non-vascular diseases , 1997, Aging.

[44]  Santhosh K. P. Kumar,et al.  Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Lesaffre,et al.  Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[46]  A. Spiro,et al.  Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.

[47]  S. Ebrahim,et al.  Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.

[48]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[49]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[50]  J W Miller,et al.  Nutritional factors in physical and cognitive functions of elderly people. , 1992, The American journal of clinical nutrition.

[51]  B. Norrving,et al.  Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors , 1992, European journal of clinical investigation.

[52]  A. McCaddon,et al.  Alzheimer's disease: a 'cobalaminergic' hypothesis. , 1992, Medical hypotheses.

[53]  M. Beal,et al.  Neurochemical characterization of excitotoxin lesions in the cerebral cortex , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  M. Beal,et al.  Homocysteic acid lesions in rat striatum spare somatostatin—;Neuropeptide Y (NADPH-diaphorase) neurons , 1990, Neuroscience Letters.

[55]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[56]  O. Wolkowitz,et al.  RBC folic acid levels and cognitive performance in elderly patients: A preliminary report , 1988, Biological Psychiatry.

[57]  W. Endres,et al.  A new enzymatic method for pyridoxal-5-phosphate determination , 1981, Journal of Inherited Metabolic Disease.

[58]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[59]  T. Stadtman,et al.  Vitamin B12 , 1971, Science.

[60]  D. Fuchs,et al.  Homocysteine and B vitamins in dementia. , 2001, The American journal of clinical nutrition.

[61]  C. Gottfries,et al.  Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease , 1998, Journal of Neural Transmission.

[62]  Y. Sako,et al.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.

[63]  D. Wechsler Manual for the Wechsler Adult Intelligence Scale. , 1955 .